Back to Search Start Over

MOESM1 of Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINAÂŽ): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....b9174325456fd2da1d17ea7b8f28b8d7
Full Text :
https://doi.org/10.6084/m9.figshare.5985487